US 6750241
Protein kinase inhibitors
expired A61PA61P17/06A61P19/02
Quick answer
US patent 6750241 (Protein kinase inhibitors) held by Theravance, Inc. expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61P, A61P17/06, A61P19/02, A61P3/10